Cargando…
Antiangiogenic therapies in urogenital malignancies: Fiction or fact?
The use of antiangiogenic agents in cancer therapy has become an attractive target in oncological research. However, concerning the uro-oncological field, current guidelines only recommend the use of antiangiogenic agents in metastatic renal cell cancer. Yet in recent years, several approaches for s...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Vienna
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725505/ https://www.ncbi.nlm.nih.gov/pubmed/29250197 http://dx.doi.org/10.1007/s12254-017-0375-8 |